Tyra Biosciences, Inc.

NASDAQ:TYRA

Biotechnology

Healthcare
$19.61 -2.48%

-$0.72 today

Market cap
$1.35B
Beta
0.75
P/E (TTM)
-13.4
EPS (TTM)
-$2.12
52W Low $8.98High $40.65

Volume 0.47M

Average 0.96M

TYRA EBITDA Margin

EBITDA as a percentage of revenue.

No reported EBITDA Margin figures are available to summarize.

EBITDA Margin history

Percent of revenue · from the income statement

No EBITDA Margin data reported for this period type.

EBITDA Margin vs competitors

How TYRA compares with its peers on the latest reported figures

TYRA Competitors Peer median
EBITDA Margin for TYRA and competitors
Company Period LTM level YoY 3-year change
MGNXMacroGenics, Inc.LTM Mar 2026-32.2% -1.2 pp+32.0 pp
NUVBNuvation Bio Inc.LTM Jun 2026-74.8% +1326.6 pp—
FHTXFoghorn Therapeutics Inc.LTM Mar 2026-257.0% +77.3 pp+319.4 pp
VSTMVerastem, Inc.LTM Mar 2026-387.1% +1063.3 pp+2084.9 pp
KURAKura Oncology, Inc.LTM Mar 2026-408.0% -146.3 pp—
JANXJanux Therapeutics, Inc.LTM Mar 2026-520.3% +290.5 pp-393.5 pp
TYRATyra Biosciences, Inc.FY2025— ——
ORICORIC Pharmaceuticals, Inc.FY2025— ——
AVBPArriVent BioPharma, Inc. Common StockFY2025— ——
CGEMCullinan Therapeutics, Inc.FY2025— ——
BCAXBicara Therapeutics Inc. Common StockFY2025— ——
Peer median (excluding TYRA) -322.1%+183.9 pp+175.7 pp

Competitors are the stored peer set for TYRA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue00000
Cost of Revenue00000
Gross Profit00000
Gross Margin—————
Research & Development20.64M43.01M62.52M80.08M102.93M
Selling, General & Admin5.65M15.92M17.43M24.1M29.83M
Operating Expenses26.29M58.93M79.95M104.18M132.76M
Depreciation & Amortization140K296K357K519K546K
EBITDA(26.15M)(55.03M)(68.78M)(85.96M)(119.4M)
EBITDA Margin—————
Operating Income(26.29M)(58.93M)(79.95M)(104.18M)(132.76M)
Operating Margin—————
Interest Income13K3.65M10.81M17.7M12.82M
Interest Expense00000
Other Income / Expenses(6K)3.6M10.81M17.7M12.82M
Income Before Tax(26.29M)(55.33M)(69.13M)(86.48M)(119.95M)
Pre-Tax Margin—————
Income Tax Expense00000
Net Income(26.29M)(55.33M)(69.13M)(86.48M)(119.95M)
Net Margin—————
EPS (Basic)(0.63)(1.23)(1.62)(1.51)(2.01)
EPS (Diluted)(0.63)(1.23)(1.62)(1.51)(2.01)
Weighted Avg Shares41.44M41.88M42.7M57.22M59.6M
Weighted Avg Shares (Diluted)41.44M41.88M42.7M57.22M59.6M

Tyra Biosciences, Inc.

NASDAQ:TYRA

Intrinsic Alpha fair value

Locked

Current Price

$19.61

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.